Research Journal of Pharmacy and Technology
SCOPUS
  • Year: 2024
  • Volume: 17
  • Issue: 7

Correlation study of plasma homocysteine with PANSS and BPRS of newly detected schizophrenic patients

  • Author:
  • Neelam Mehta1, Itishri Jena2,*, Subhashree Ray2, Sudeshna Behera2, Surjeet Sahoo3
  • Total Page Count: 4
  • Page Number: 3009 to 3012

1Department of Pathology, TATA Main Hospital, Jamshedpur, 831001, Jharkhand, India

2Department of Biochemistry, IMS and SUM Hospital, Bhubaneswar, 751003, Odisha, India

3Department of Psychiatry, IMS and SUM Hospital, Bhubaneswar, 751003, Odisha, India

*Corresponding Author E-mail: dritishrijena82@gmail.com

Online published on 29 April, 2025.

Abstract

The underlying etiopathogenesis of long-term psychiatric disorder schizophrenia is not clear. Hyperhomocystenemia is known to play important role in ethiopathogenesis and development of many cognitive disorder including schizophrenia. The present study was undertaken to find out the association between plasma homocysteine with Positive And Negative Syndrome Scale (PANSS) and Brief Psychiatric Rating Scale (BPRS) of newly detected schizophrenic patients. PANSS and BPRS are commonly used symptoms rating scale of schizophrenia. Assessment of plasma homocysteine, PANSS and BPRS were done in 30 schizophrenic patients and compared with 50 gender and age matched healthy individuals. The plasma homocysteine, BPRS score and PANSS score of schizophrenic patients were 15.48±2.71 μmol/L, 84.2±1.72, 149.01±1.72 respectively, which were significantly high in comparison to controls. This raised value of homocysteine is also positively and significantly correlated with BPRS and PANSS of study population. This study suggests the role of high homocysteine level in development and progression of schizophrenia.

Keywords

Psychiatric disorder, Schizophrenia, Hyperhomocysteinemia, PANSS, BPRS